InspireMD (STU:II2) Inventory Turnover: 0.85 (As of Mar. 2026)

What is InspireMD Inventory Turnover?

InspireMD STU:II2 -4.10% 42 Inventory Turnover is 0.85 as of Mar. 2026. GuruFocus rates STU:II2 with a GF Score™ of 42/100 and a GF Value™ of €1.55 (Possible Value Trap). The stock has 3 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. InspireMD's Cost of Goods Sold for the three months ended in Mar. 2026 was €2.35 Mil. InspireMD's Average Total Inventories for the quarter that ended in Mar. 2026 was €2.76 Mil. InspireMD's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.85.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. InspireMD's Days Inventory for the three months ended in Mar. 2026 was 107.52.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. InspireMD's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.94.

InspireMD (STU:II2) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

InspireMD's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	2.763	/	2.345	*	365 / 4
	=	107.52

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

InspireMD's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	2.763	/	2.939
	=	0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

InspireMD Inventory Turnover Related Terms

InspireMD Inventory Turnover Historical Data

* Premium members only.

The historical data trend for InspireMD's Inventory Turnover can be seen below:

InspireMD Inventory Turnover Chart

InspireMD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

3.04

3.01

2.33

2.40

2.02

InspireMD Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.45	0.48	0.49	0.56	0.85

42GF Score

InspireMD Inc STU:II2

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

InspireMD Inventory Turnover Calculation

InspireMD's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	5.406	/ (	(2.454	+	2.9)	/	2 )
=	5.406	/	2.677
=	2.02

InspireMD's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	2.345	/ (	(2.9	+	2.626)	/	2 )
=	2.345	/	2.763
=	0.85

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.85 mean?

InspireMD (STU:II2) has a Inventory Turnover of 0.85 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on InspireMD and its competitors.

Is InspireMD's Inventory Turnover too high?

InspireMD's current Inventory Turnover is 0.85. Overall, InspireMD has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does InspireMD's Inventory Turnover compare to TELA and BDMD?

InspireMD's Inventory Turnover of 0.85 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Devices & Instruments company?

A good Inventory Turnover depends on the Medical Devices & Instruments industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on InspireMD and its competitors. InspireMD's current Inventory Turnover is 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is InspireMD stock overvalued right now?

Based on GuruFocus' analysis, InspireMD (STU:II2) is currently considered Possible Value Trap. The stock's GF Value™ is €1.55, compared to a current price of €0.59 — trading 62.3% below its estimated fair value. The current Inventory Turnover is 0.85. InspireMD's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For InspireMD (STU:II2), the current Inventory Turnover is 0.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InspireMD (STU:II2) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of €0.59 is trading 62.3% below its estimated GF Value™ of €1.55. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for STU:II2:

Inventory Turnover: 0.85
GF Value™: €1.55 vs. price of €0.59 (62.3% below fair value)
GF Score™: 42/100 with 3 warning signs

No single metric tells the full story. See the STU:II2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InspireMD Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TELA BDMD PAVM ARAY PETV FOFA RDGL NMTC TANAF MYO ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges NSPR:USA

Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126

Website https://www.inspiremd.com

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

42GF Score

Get the complete analysis for STU:II2

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.59

Price

€1.55

GF Value

View STU:II2 Analysis

See Inventory Turnover data for all stocks →